Business
Notice of AGM and Posting of Accounts
Notice of AGM and Posting of Accounts.
About this update from 4basebio Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n \n \n \n 4basebio UK Societas\n (the \"Company\")\n Notice of Annual General Meeting\n Posting of Annual Report and Financial Statements\n 4basebio UK Societas (AIM: 4BB), the specialist life sciences group focused on exploiting intellectual property in the field of gene therapies and vaccines, confirms that the Annual Report and Accounts for the year ended 30 December 2020, and the Notice of Annual General Meeting (\"AGM\") with accompanying Form of Proxy has been posted to shareholders today.\n These documents are also available, in electronic form, for download on the Company's website: https://www.4basebio.com/investors/.\n The Company‘s AGM will be held at 09:00 a.m. on Wednesday, 30 June 2021 at the Company’s offices at 25 Norman Way, Over, CB24 5QE. This will be followed by a presentation from the Company through the Investor Meet Company platform on 1 July 2021 at 10am. Investors can sign up to Investor Meet Company for free and register interest here: https://www.investormeetcompany.com/4basebio-uk-societas/register-investor\n The Company continues to monitor developments relating to the outbreak of COVID-19, including the related public health guidance and legislation issued by the UK Government as well as the “roadmap out of lockdown” published on 22 February 2021. At present, it is expected that it will be possible to hold a physical AGM and to welcome the maximum number of shareholders we are able within safety constraints and in accordance with government guidelines that will apply at the time. \n However, given the constantly evolving nature of the situation, we want to ensure that we are able to adapt these arrangements efficiently to respond to changes in circumstances. On this basis, should the situation change such that we consider that it is no longer possible for shareholders to attend the meeting, we will adopt contingency plans and notify shareholders of the change via an RNS announcement as early as is possible before the date of the meeting. Such contingency plans are likely to result in the holding of a virtual or hybrid meeting. Any updates to the position will also be included on our website at https://www.4basebio.com/investors/. Should we have to change the arrangements in this way, it is likely that we will not be in ...